Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results.

Annieke C G van Baar,Ulrich Beuers,Kari Wong,Rehan Haidry,Guido Costamagna, Alia Hafedi,Jacques Deviere,Soumitra S Ghosh,Juan Carlos Lopez-Talavera,Leonardo Rodriguez,Manoel P Galvao Neto,Arun Sanyal,Jacques J G H M Bergman

JHEP Reports（2019）

引用 27|浏览9

暂无评分

摘要

Insulin resistance is a core pathophysiological defect underscoring type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). Both conditions improve with duodenal exclusion surgery. Duodenal mucosal resurfacing (DMR) is an endoscopic intervention developed to treat metabolic disease which has been shown to improve glycaemia in patients with poorly controlled T2DM. Herein, we aimed to further analyse the effects of DMR on hepatic and metabolic parameters in this patient cohort.

查看译文

关键词

Duodenal Mucosal Resurfacing,therapeutic endoscopy,Type 2 Diabetes Mellitus,T2DM,Metabolic Syndrome,Blood Glucose,Glycated Haemoglobin A1c,NAFLD,Non-Alcoholic Fatty Liver Disease,Aminotransferase levels,Insulin Resistance,Metabolomics

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要